DBS for Obsessive-Compulsive Disorder
Key facts
- Who runs it
- Northwell Health
- Where
- Queens, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 6 Jul 2024
- Expected to end
- 1 Jan 2030
- Type of study
- Interventional
- Treatments tested
- Reclaim™ DBS Therapy
- Record updated
- 29 October 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Have a diagnosis of OCD with a documented duration of at least 5 years
- Have OCD rated as severe or extreme illness
- Have failed to improve following treatment with at least 3 selective serotonin reuptake inhibitors (SSRIs) and clomipramine
- Do not have hoarding as their primary subclassification
- Have completed or tried to complete Exposure and Response Prevention Therapy (ERP)
- Have no serious psychiatric disorder in addition to OCD (e.g. comorbid personality disorder) or current substance abuse issues
- Meet established criteria for implantation of a deep brain stimulation system
- Are 18 years old or older
- Have not had a previous surgery to destroy the region of the brain that will be the target of stimulation
- Are not pregnant
- Have no other neurological disorders, including dementia
- Do not have a bleeding disorder or are not taking blood thinners
- Are capable of giving informed consent
Who cannot take part
- Patients who are unable to properly operate the neurostimulator
- Patients who will be exposed to diathermy
Where in United States
- Zucker Hillside HospitalQueens, United StatesContact: Jenna SchugartTaking people
About the trial
What the trial wants to find out
There are two primary approaches to the treatment of OCD, pharmacotherapy and cognitive behavior therapy (CBT). Lack of therapeutic success with one approach leads to trials of the alternative approach or a combination of the two. A rarely used third therapy approach, appropriate for only the most severely afflicted and treatment resistant patients, is neurosurgical ablation of certain brain regions involved in mood and anxiety. The neurosurgical ablation procedures are irreversible in nature, and involve the destruction of specific volumes of brain tissue through various controlled means.
Read full original descriptionShow less
Surgical procedures include cingulotomy, subcaudate tractotomy, limbic leucotomy which is a combination of the first two procedures and capsulotomy. DBS therapy is an alternative to neurosurgical procedures, specifically anterior capsulotomy, for patients with chronic, severe OCD which has proven resistant to primary pharmacological and/or behavior therapy options.
Results from 26 severe, treatment-resistant OCD patients treated with DBS at four collaborating centers, three in the US, and one in Europe are summarized in great detail in pages 12-22 of the provided/attached "Reclaim Summary of Safety and Probable Benefit."
The group in the trial
- Reclaim™ DBS TherapyTreatment being tested
Procedure: The DBS lead is stereotactically introduced into the target in the brain and fixed to the skull; the lead is then connected to a neurostimulator implanted subcutaneously in the subclavicular region. This is performed by a neurosurgeon skilled in this technique, as the same procedure is routinely performed in patients with other diseases (using other brain targets).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)
- Record updated
- 29 October 2025